secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hyperfine, Inc. (HYPR)
CIK:        0001833769
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0000950170-23-051513
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hyperfine terminates CMO/CSO Khan Siddiqui; transitions to consultant
---------------------------------------------------------------------

- Khan Siddiqui terminated as Chief Medical Officer and Chief Strategy Officer effective September 30, 2023.
- Will continue as consultant at $300/hour; salary paid through separation date.
- Outstanding equity awards to continue vesting during consulting period under 2021 Equity Plan.
- Separation agreement includes $500 payment, standard release, and non-disparagement.
- No replacement named for the dual roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833769/000095017023051513/0000950170-23-051513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833769/000095017023051513/hypr-20230927.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-051513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer